PHAT Q1 2022 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$128,000

Operating Income

-$38M

Net Income

-$41M

EPS (Diluted)

$-1.14

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$45M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$149M

Total Liabilities

$111M

Stockholders' Equity

$38M

Cash & Equivalents

$138M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$128,000	-$125,000	-2.4%
Operating Income	-$38M	-$34M	-12.9%
Net Income	-$41M	-$35M	-16.7%